Esperion Therapeutics | Passivo Circulante





Passivo Circulante Alterar Data
AbbVie USD 39.39B 376M 2025-09
Alnylam Pharmaceuticals USD 1.56B 254.63M 2025-09
Alterity Therapeutics Limited AUD 4.38M 849.82K 2023-06
Amarin USD 182.23M 3.71M 2025-09
Amgen USD 25.49B 3.7B 2025-12
Biogen USD 3.35B 59.4M 2025-12
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Cipla INR 62.97B 8.13B 2025-09
CSL USD 4.82B 1.26B 2025-06
Cytokinetics USD 142.14M 11.08M 2025-09
Daiichi Sankyo JPY 778.55B 77.51B 2025-12
Eli Lilly USD 40.14B 1.12B 2025-09
Esperion Therapeutics USD 359.03M 60.24M 2025-09
Geron USD 87.71M 23.43M 2025-09
Grifols EUR 2.53B 182.67M 2025-09
Halozyme Therapeutics USD 837.23M 702.95M 2025-09
Heron Therapeutics USD 89.71M 168.89M 2025-09
Ionis Pharmaceuticals USD 903.46M 6.22M 2025-09
Merck USD 28.63B 2.59B 2025-09
Minerva Neurosciences USD 2.67M 143K 2025-09
Moderna USD 1.68B 109M 2025-09
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
PTC Therapeutics USD 866.24M 238.44M 2025-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Sanofi EUR 28.35B 3.76B 2025-12
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
United Therapeutics USD 546.3M 19.2M 2025-09
Vanda Pharmaceuticals USD 117.87M 3.62M 2025-09


Esperion Therapeutics Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.